ELANE and ulcerative colitis: This study demonstrated that elastase can affect the integrity or therapeutic monoclonal antibodies as well as therapeutic fusion proteins such as etanercept, suggesting that the high content of neutrophil elastase in tissues from ulcerative colitis patients could contribute to an impaired response to biological drugs.